Phenominer Database Results (1652 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Average Type Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
BB.SHR-(D6Rat184-D6Rat3)/K body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. body mass male 84 days 17 324.0 g 6.79 28.0 body weighing method 0.0 0 66144 324
SHR/FubRkb body weight control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 body mass not specified 168 days 10 377.5 g 4.4 13.91 body weighing method 0.0 0 65358 117
MWF-Chr 6SHR/Rkb body weight control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 body mass not specified 168 days 19 375.0 g 8.9 38.79 body weighing method 0.0 0 65359 117
SS/JrSeac body weight controlled sodium content diet (0.3 %) (for 35 days) Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. body mass not specified 77 days 5 247.0 g 7.6 17.0 body weighing method 0.0 0 67253 733
SS/JrSeac body weight controlled sodium content diet (8 %) (for 35 days) Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. body mass not specified 126 days 5 273.0 g 6.26 14.0 body weighing method 0.0 0 67256 733
SS/JrHsdMcwi body weight controlled sodium content diet (0.4 %) Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. body mass female 84 days 28 230.0 g 3.0 15.87 body weighing method 0.0 0 after catheterization and jacket attachment 67294 151
BN.GK-(D8Rat29-D8Got130)/Ox body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass male 84 days 11 234.0 g 5.0 16.58 body weighing method 0 11290 66
BN.GK-(D2Rat40-D2Got149)/Ox body weight control condition Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. body mass male 90 days 15 248.0 g 4.0 15.49 body weighing method 0 11302 69
GK/KyoSwe body weight control condition Galli J, et al., NatGenet 1996 Jan;12(1):31-7. body mass not specified 80 days 8 228.0 g 19.0 53.74 body weighing method 0.0 0 11392 82
F344/DuCrlCrlj body weight control condition (for 95 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 95 days 15 279.0 g 4.0 15.49 body weighing method 0.0 0 11444 85
F344.GK-(D1Mgh10-D1Rat119)/Swe body weight control condition (for 65 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 65 days 11 228.0 g 4.0 13.27 body weighing method 0.0 0 11466 85
F344.GK-(D1Mgh10-D1Rat119)/Swe body weight control condition (for 185 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 185 days 10 386.0 g 4.0 12.65 body weighing method 0.0 0 11487 85
GH/Omr body weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. body mass male 132 days-146 days 21 365.4 g 3.71 17.0 body weighing method 0 11527 101
SHR/Izm body weight control condition Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7 body mass male 168 days 6 348.0 g 3.67 9.0 body weighing method 0 11579 103
WKY/NHsd body weight fasting (for 16 hours) Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 body mass male 119 days 10 352.0 g 4.5 14.23 body weighing method 0 0 11608 107
WKY/NHsd body weight fasting (for 16 hours) Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 body mass female 119 days 10 230.0 g 3.2 10.12 body weighing method 0 0 11610 107
WKY/NCruk body weight control condition Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 body mass male 175 days 19 329.3 g 5.62 24.5 body weighing method 0 11641 110
LEW/NCrl body weight controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 56 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass male 91 days 8 352.0 g 4.6 13.01 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 64710 222
SS.LEW-(D10Mit10-D10Mgh1)/Jr body weight controlled sodium content diet (2 %) (between 24 and 27 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass not specified 64 days-71 days 20 292.0 g 2.1 9.39 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 64725 222
SS/Jr body weight controlled sodium content diet (2 %) (between 24 and 27 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass not specified 64 days-71 days 20 290.0 g 1.9 8.5 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 64718 222
SS/Jr body weight controlled sodium content diet (2 %) (for 24 days) Rapp JP, et al., Genomics 1998 Jul 15;51(2):191-6 body mass male 62 days 20 324.0 g 2.5 11.18 body weighing method 0 0 65831 633
SHR/OlaIpcv body weight control condition Pravenec M, et al., Physiol Res 2003;52(3):285-9. body mass male 80 days-100 days 10 291.9 g 11.4 36.05 body weighing method 0.0 0 65505 612
F344/NSlc body weight fasting (between 16 and 18 hours) Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. body mass male 210 days 9 387.4 g 10.3 30.9 body weighing method 0 0 66178 716
ACI/Eur body weight right nephrectomy Van Dijk SJ, et al., Kidney Int. 2006 body mass male 168 days-175 days 12 315.0 g 3.0 10.39 body weighing method 0 11930 62
F344.OLETF-(D1Rat166-D1Rat90)/Tj body weight control condition Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. body mass male 245 days 9 483.1 g 6.8 20.4 body weighing method 0 12442 262
SHR/Izm body weight controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. body mass male 119 days 10 288.0 g 1.42 4.5 body weighing method 0 12449 263
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 302.0 g 3.24 14.49 body weighing method 0 12490 266
BC/CpbU body weight controlled olive oil content diet (5 %) (for 30 days) and controlled cholesterol content diet (2 %) (for 30 days) de Wolf ID, et al., Exp Biol Med (Maywood) 2002 Jul;227(7):529-34. body mass female 77 days 4 177.0 g 2.5 5.0 body weighing method 0 12512 267
LEW/OlaHsd body weight control condition Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9. body mass female 49 days 6 160.0 g 3.27 8.0 body weighing method 0 12611 271
SS.SR-(D7Mco7-D7Wox19)/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. body mass male 68 days-70 days 20 299.4 g 2.8 12.52 body weighing method 0 11824 147
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. body mass male 68 days-70 days 20 289.8 g 3.2 14.31 body weighing method 0 11817 147
OLETF/Got body weight control condition Ogino Genom 2000 Nov 15;70(1):19-25. body mass male 245 days-252 days 14 650.6 g 8.61 32.2 body weighing method 0 11406 83
SS.LEW-(D1Mco36-D1Rat131)/2Mco body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. body mass male 64 days-66 days 20 306.0 g 1.91 8.54 body weighing method 0 0 12874 313
SS.LEW-(D1Mco99-D1Rat49)/Mco body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. body mass male 64 days-66 days 20 302.0 g 1.89 8.45 body weighing method 0 0 12879 313
WBN/KobSlc body weight controlled protein content diet Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. body mass male 120 days 5 332.7 g 6.1 13.64 body weighing method 0 12906 321
WKY body weight controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. body mass male 360 days 4 318.0 g 6.65 13.3 body weighing method 0 0 12588 268
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Hypertension. 2007 body mass male 64 days-66 days 0 302.0 g 5.58 body weighing method 0 11974 205
SR/Jr body weight controlled sodium content diet (0.2 %) (for 28 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass male 63 days 10 238.0 g 4.7 14.86 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 12180 222
LEW/NCrl body weight controlled sodium content diet (0.2 %) (for 168 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass male 203 days 8 506.0 g 12.4 35.07 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 12192 222
LEW/NCrl body weight controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 168 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass male 203 days 8 452.0 g 5.2 14.71 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 12200 222
F344/NRrrc body weight control condition Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50. body mass male 245 days 7 375.6 g 7.56 20.0 body weighing method 0 12202 234
SS/Jr body weight controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. body mass male 70 days-72 days 40 318.6 g 2.6 16.44 body weighing method 0 12282 237
F344.OLETF-(D14Rat8-D14Rat26)/Tj body weight fasting (for 16 hours) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. body mass male 210 days 14 392.2 g 5.2 19.46 body weighing method 0 12074 230
SS/Jr body weight controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. body mass male 70 days-72 days 41 326.2 g 2.1 13.45 body weighing method 0 12305 237
SS/Jr body weight controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Mamm Genome. 2008 Jan 4 body mass male 64 days-68 days 20 312.0 g 3.22 14.4 body weighing method 0 0 12143 232
SHR/N body weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. body mass female 84 days 16 331.0 g 24.0 96.0 body weighing method 0 13054 327
F344.GK-(D1Swe4-D1Rat85)/Swe body weight fasting (for 6 hours) Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. body mass male 95 days 24 279.0 g 1.0 4.9 body weighing method 0 0 13112 330
F344/NSlc body weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. body mass male 211 days 7 393.6 g 6.2 16.4 body weighing method oral glucose 0 min 12785 311
SS/Jr body weight controlled sodium content diet (2 %) (for 28 days) Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. body mass male 68 days-70 days 20 318.0 g 2.09 9.35 body weighing method 0 12947 305
BB.SHR-(D6Rat184-D6Rat3)/K body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. body mass female 84 days 24 200.0 g 3.06 15.0 body weighing method 0.0 0 12976 324
SS.LEW-(D18Rat30-D18Chm29)/Ayd body weight controlled sodium content diet (2 %) (between 35 and 98 days) Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 body mass male 98 days 8 378.0 g 9.0 25.46 body weighing method 0.0 0 64803 226
LEW body weight controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. body mass male 77 days 14 299.2 g 6.76 25.3 body weighing method 0 0 65004 542
SS.LEW-(D16Chm36-D16Mit2)/Ayd body weight controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. body mass male 77 days 18 319.8 g 3.54 15.0 body weighing method 0 0 65008 542
SS.LEW-(D10Got112-Igfbp4)/Ayd body weight controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. body mass male 77 days 5 318.8 g 9.03 20.2 body weighing method 0 0 65010 542
SS/HsdMcwiCrl body weight to tibia length ratio controlled carbohydrate content diet (69 %) (for 91 days) and controlled fat content diet (12 %) (for 91 days) and controlled protein content diet (19 %) (for 91 days) Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. body mass male 112 days 6 96.12 g/cm 1.28 3.14 body weighing method 0.0 0 67616 735
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur body weight unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. body mass male 173 days-180 days 10 301.0 g 4.0 12.65 body weighing method 0.0 0 67679 751
ACI.FHH-(D1Rat324-D1Rat156)/Eur body weight unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. body mass male 173 days-180 days 8 284.0 g 5.0 14.14 body weighing method 0.0 0 67680 751
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. body mass not specified 0 days 0 353.0 g 6.24 body weighing method 0.0 0 67537 749
F344/Jcl body weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. body mass male 900 days 8 null 350.7 g body weighing method 0 method not specified, assumed to be digital scale 13302 341
SHR.BN-(D16Rat87-D16Mgh1)/Jk body weight controlled sodium content diet (1 %) (for 14 days) Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. body mass male 87 days 23 271.0 g 5.0 23.98 body weighing method 0 0 65437 306
WKY/Izm body weight control condition (0 null) Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. body mass female 91 days 5 200.8 g 3.1 6.93 body weighing method 0 0 64833 115
SS/Jr body weight control condition Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87 body mass male 182 days-183 days 6 485.0 g 11.9 29.15 body weighing method 0 0 65446 104
F344/NHsd body weight air oxygen content (10 %) (for 21 days) Zhao L et al., 2001, Circulation, 103(3), 442-7 body mass male 105 days 23 median 238.0 g body weighing method 0 0 66124 102
N:HS body weight control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 body mass both 70 days 220 234.2 g 3.85 57.1 body weighing method 0 0 66005 114
SS/JrRkb body weight controlled sodium content diet (4 %) (for 56 days) Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. body mass male 98 days 14 342.0 g 6.0 22.45 body weighing method 0 0 66083 669
SS/HsdMcwiCrl body weight to tibia length ratio controlled carbohydrate content diet (53 %) (for 91 days) and controlled fat content diet (14 %) (for 91 days) and controlled protein content diet (33 %) (for 91 days) Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. body mass male 112 days 7 100.21 g/cm 1.76 4.66 body weighing method 0.0 0 67614 735
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur body weight unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. body mass male 173 days-180 days 9 284.0 g 6.0 18.0 body weighing method 0.0 0 67682 751
ACI.FHH-(D1Rat324-D1Rat156)/Eur body weight unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. body mass male 173 days-180 days 8 235.0 g 9.0 25.46 body weighing method 0.0 0 67683 751
BN/Crl body weight fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. body mass male 60 days 6 191.0 g 4.0 9.8 body weighing method 0.0 0 68768 1012
WOKW/K body weight control condition Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. body mass not specified 224 days 12 513.0 g 5.77 20.0 body weighing method 0.0 0 69108 1123
DA/K body mass index (BMI) control condition Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. body mass not specified 224 days 12 0.62 g/cm2 0.01 0.04 body weighing method 0.0 0 69111 1123
BN/Cub body weight controlled sucrose content diet (for 7 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. body mass male 307 days 6 291.1 g 10.29 25.2 body weighing method 0.0 0 70208 1318
DA.ACI-(D10Rat2-D10Rat29)/Kini maximum body weight loss to initial body weight ratio myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. body mass male 103 days-131 days 10 1.2 % 1.14 3.6 body weighing method 0.0 intradermal injection 40 days from before p.i. 68720 839
ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur body weight unilateral nephrectomy van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. body mass not specified 168 days-175 days 12 304.0 g 4.0 13.86 body weighing method 0.0 unilateral nephrectomy 126 days 67902 832
ACI.FHH-(D1Rat384-D1Rat156)/Eur body weight unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. body mass not specified 168 days-175 days 11 267.0 g 11.0 36.48 body weighing method 0.0 unilateral nephrectomy 126 days 67908 832
ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur body weight unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. body mass not specified 168 days-175 days 2 286.0 g 1.0 1.41 body weighing method 0.0 unilateral nephrectomy 126 days 67909 832
E3/Ztm body weight gain spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 body mass female 56 days-103 days 12 80.0 g 0.87 3.0 body weighing method 0.0 0 69956 1258
ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur body weight NG-nitroarginine methyl ester (9-16 mg/kg/d) (for 126 days) van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. body mass not specified 168 days-175 days 12 285.0 g 8.0 27.71 body weighing method 0.0 0 67937 832
SS.SHR-(D2Rat61-D2Mco18)/Mco body weight control condition (for 140 days) Garrett MR, et al., Physiol Genomics. 2007 May 15;. body mass male 140 days 6 435.0 g 10.0 24.49 body weighing method 0.0 0 67974 834
DA/ZtmKini body weight control condition Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. body mass female 56 days-77 days 0 162.9 g 9.5 body weighing method 0.0 0 68120 837
DA.ACI-(D10Rat2-D10Rat29)/Kini maximum body weight loss to initial body weight ratio myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. body mass male 103 days-131 days 7 0.0 % 0.0 0.0 body weighing method 0.0 intradermal injection 40 days from before p.i. 68728 839
DA/Ztm maximum body weight loss to initial body weight ratio squalene (200 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 15 12.8 % 0.6 2.32 body weighing method 0.0 0 69794 1162
DA.PVG.1AV1-(D4Rat155-D4Rat84) maximum body weight loss to initial body weight ratio Freund's complete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 14 5.9 % 3.7 13.84 body weighing method 0.0 0 69797 1162
DA.PVG.1AV1-(D4Rat63-D4Rat203) maximum body weight loss to initial body weight ratio squalene (200 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 10 6.6 % 2.5 7.91 body weighing method 0.0 0 69808 1162
DA/Ztm maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 10 22.8 % 1.1 3.48 body weighing method 0.0 0 69809 1162
DA/Ztm maximum body weight loss to initial body weight ratio pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 10 14.3 % 2.5 7.91 body weighing method 0.0 0 69811 1162
Crl:CD(SD) body weight standard diet then acetaminophen (500 mg/kg) (for 1 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 71 days 8 375.0 g 6.36 18.0 body weighing method 0.0 0 85520 1604
Crl:CD(SD) body weight standard diet then acetaminophen (500 mg/kg) (for 35 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 105 days 8 472.0 g 8.49 24.0 body weighing method 0.0 0 85532 1604
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 98 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 168 days 8 447.0 g 16.62 47.0 body weighing method 0.0 0 85552 1604
W-LeprfaNin body weight controlled retinyl palmitate content diet (2.6 mg/kg) (between 36 and 42 days) then fasting (for 12 hours) Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2. body mass male 284 days 6 926.0 g 56.2 137.66 body weighing method 0.0 0 96721 1660
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 168 days 19 444.0 g 6.65 29.0 body weighing method 0.0 0 85321 1604
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 35 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 105 days 8 365.0 g 6.36 18.0 body weighing method 0.0 0 85535 1604
W-LeprfaNin body weight controlled retinyl palmitate content diet (52 mg/kg) (between 36 and 42 days) then fasting (for 12 hours) Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2. body mass male 284 days 6 811.0 g 33.4 81.81 body weighing method 0.0 0 96723 1660
BluHsd:LE body weight controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days) Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. body mass male 70 days 8 339.6 g 9.5 26.87 body weighing method 0.0 0 76146 1543
BluHsd:LE body weight gain controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days) Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. body mass male 71 days-98 days 8 150.1 g 4.7 13.29 body weighing method 0.0 0 76163 1543
HanTac:WH body weight gain bisphenol A (5 mg/kg/d) (for 14 days) Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014. body mass female 0 days 18 81.1 g 4.9 20.8 body weighing method 0.0 0 G7-G21 76273 1559
F344/NHsd body weight fasting (for 16 hours) Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17. body mass male 132 days-264 days 9 375.7 g 8.1 24.3 body weighing method 0.0 0 84703 1599
F344/NHsd body weight control condition Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17. body mass male 132 days-264 days 5 381.2 g 9.4 21.02 body weighing method 0.0 0 84708 1599
SD body weight acetaminophen (500 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 70 days-84 days 6 256.6 g body weighing method 0.0 0 84774 1602
SD body weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 70 days-84 days 6 262.4 g body weighing method 0.0 0 84779 1602
SD body weight acetaminophen (1000 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 42 days-56 days 6 190.7 g body weighing method 0.0 0 84789 1602
CrljJcl:SD body weight gestation (for 21 days) then lactation (for 14 days) Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17. body mass female 0 days 6 264.54 g 14.41 35.3 body weighing method 0.0 0 75904 1539
CrljJcl:SD body weight gestation (for 21 days) then controlled bisphenol A content drinking water (0.1 mg/l) (for 24 days) then lactation (for 14 days) Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17. body mass female 0 days 8 264.83 g 21.28 60.19 body weighing method 0.0 0 75914 1539
Hsd:WI body weight silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. body mass male 0 days 6 143.6 g 0.41 1.0 body weighing method 0.0 0 75954 1544
BluHsd:LE body weight vehicle control condition (for 30 days) and controlled in utero environment (for 9 days) then maternal milk (for 21 days) Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. body mass male 98 days 8 457.7 g 15.9 44.97 body weighing method 0.0 0 75962 1543
Hsd:WI body weight vehicle control condition (for 91 days) Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. body mass male 119 days-126 days 5 388.0 g 16.82 37.6 body weighing method 0.0 0 76041 1545
Hsd:WI body weight bisphenol A (125 mg/kg/d) (for 91 days) Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. body mass male 119 days-126 days 6 314.83 g 6.15 15.07 body weighing method 0.0 0 76042 1545
Hsd:WI change in body weight to body weight ratio octylphenol (250 mg/kg/d) (for 91 days) Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. body mass male 119 days-126 days 6 212.8 % 16.9 41.4 body weighing method 0.0 0 76069 1545
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 84 days 19 328.0 g 4.82 21.0 body weighing method 0.0 0 85313 1604
Crl:SD body weight gain controlled fructose content drinking water (5 %) (for 70 days) and controlled bisphenol A content drinking water (0.025 mg/l) (for 70 days) Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. body mass female 35 days-105 days 12 88.3 g 2.22 7.7 body weighing method 0.0 0 week one 75759 1538
SD body weight acetaminophen (500 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 57 days-71 days 6 229.6 g body weighing method 0.0 0 84772 1602
F344/NHsd body weight fasting (for 16 hours) Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17. body mass male 579 days-945 days 9 419.9 g 12.2 36.6 body weighing method 0.0 0 84705 1599
F344/NHsd body weight fasting (for 16 hours) Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17. body mass male 714 days-882 days 5 415.7 g 28.9 64.62 body weighing method 0.0 0 84706 1599
SHR-Ndufc2em1Mcwi+/+ body weight controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 98 days 10 287.0 g 3.79 12.0 body weighing method 0.0 0 97878 1938
PXO6-3/Cub body weight controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours) Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014. body mass male 127 days 10 235.6 g 6.8 21.5 body weighing method 0.0 0 97159 1858
W-LeprfaNin body weight controlled retinyl palmitate content diet (129 mg/kg) (between 36 and 42 days) then fasting (for 12 hours) Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2. body mass male 284 days 6 778.0 g 23.8 58.3 body weighing method 0.0 0 96724 1660
PXO9/Cub body weight controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours) Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014. body mass male 127 days 9 245.0 g 6.2 18.6 body weighing method 0.0 0 97160 1858
PXO3-2/Cub body weight controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours) Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014. body mass male 127 days 9 307.6 g 5.8 17.4 body weighing method 0.0 0 97171 1858
SHR-Ndufc2em2Mcwi+/+ body weight controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 98 days 12 299.0 g 4.62 16.0 body weighing method 0.0 0 97901 1938
SHR-Ndufc2em2Mcwi+/+ body weight controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 126 days 12 314.0 g 14.15 49.0 body weighing method 0.0 0 97902 1938
SHR-Ndufc2em2Mcwi-/+ body weight controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 98 days 24 293.0 g 6.12 30.0 body weighing method 0.0 0 97904 1938
SHR/Bbb body weight controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 98 days 18 260.0 g 3.77 16.0 body weighing method 0.0 0 97907 1938
SS-Plod1em1Mcwi-/- body weight controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. body mass male 60 days-69 days 0 298.0 g 6.0 body weighing method 0.0 0 98465 2059
MW body weight right nephrectomy (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 6 258.7 g 11.0 26.94 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100799 2523
MW body weight right nephrectomy (for 56 days) then enalapril (20 mg/kg/d) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 9 280.5 g 1.1 3.3 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100802 2523
SS/JrTol body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. body mass male 73 days-75 days 10 338.0 g 4.0 12.65 body weighing method 0.0 0 96966 1778
SS.LEW-(D1Rat200-D1Mco136)/Bj body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. body mass male 73 days-75 days 10 331.0 g 5.0 15.81 body weighing method 0.0 0 96968 1778
Jcl:WI body weight standard diet Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. body mass male 84 days 8 432.0 g 10.25 29.0 body weighing method 0.0 0 103055 2785
SD body weight in utero condition (for 7 days) and corn oil (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. body mass male 1 days 0 6.34 g 0.34 body weighing method 1.0 0 98736 2158
SS-Nppbem2Mcwi-/- body weight control condition (for 28 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. body mass male 28 days 7 79.0 g 21.0 55.56 body weighing method 0.0 0 99544 2319
SS-Nppbem2Mcwi+/+ body weight control condition (for 56 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. body mass male 56 days 5 267.0 g 5.0 11.18 body weighing method 0.0 0 99545 2319
SS-Nppbem2Mcwi-/- body weight control condition (for 56 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. body mass male 56 days 6 253.0 g 30.0 73.48 body weighing method 0.0 0 99546 2319
WKY/NCrl body weight control condition Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. body mass male 140 days 6 437.0 g 3.0 7.35 body weighing method 0.0 0 103487 2827
GK body weight control condition Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. body mass male 140 days 6 359.0 g 6.0 14.7 body weighing method 0.0 0 103489 2827
WF/Mol body weight gain vehicle control condition then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 6 8.0 g 2.0 4.9 body weighing method 0.0 acf 7 days change from surgery weight 101342 2585
SR/JrHsd body weight controlled sodium chloride content diet (4 %) (for 14 days) then bilateral ovariectomy then peanut oil (0.2 ml) (for 14 days) Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1. body mass female 0 days 0 269.0 g 7.3 body weighing method 0.0 0 102186 2681
LL/Mav body weight vehicle control condition Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. body mass male 112 days 9 364.0 g 6.0 18.0 body weighing method 0.0 0 102722 2721
SR body weight controlled sodium content diet (6 %) (between 21 and 28 days) Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. body mass male 63 days-70 days 7 303.0 g 10.96 29.0 body weighing method 0.0 0 103344 2804
SR body weight controlled sodium content diet (6 %) (between 56 and 70 days) Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. body mass male 98 days-132 days 7 405.0 g 15.5 41.0 body weighing method 0.0 0 103346 2804
SS body weight controlled sodium content diet (6 %) (between 56 and 70 days) Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. body mass male 98 days-132 days 7 417.0 g 31.75 84.0 body weighing method 0.0 0 103349 2804
LH/Mav body weight controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days) Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. body mass male 119 days 8 393.0 g 7.0 19.8 body weighing method 0.0 0 103405 2824
LH/Mav body weight control condition (for 84 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 84 days 12 353.0 g 8.0 27.71 body weighing method 0.0 0 103424 2825
LH/Mav body weight controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 84 days 13 327.0 g 7.0 25.24 body weighing method 0.0 0 103426 2825
LH/Mav body weight control condition (between 147 and 154 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 147 days-154 days 6 433.0 g 7.0 17.15 body weighing method 0.0 0 103428 2825
WKY body weight sham surgical control condition (for 224 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 266 days-280 days 5 562.0 g 22.0 49.19 body weighing method 0.0 lad occlusion sham 210 days 100273 2460
WKY body weight left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 266 days-280 days 16 599.0 g 35.0 140.0 body weighing method 0.0 lad occlusion 210 days 100274 2460
SD body weight control condition Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. body mass female 0 days 8 305.4 g 5.3 14.99 body weighing method 0.0 - 0 days 100631 2499
SD body weight controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. body mass female 0 days 12 290.6 g 6.8 23.56 body weighing method 0.0 unx 97 days 100635 2499
Crlj:WI body weight air oxygen content (21 %) (for 28 days) Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. body mass male 16 days 6 322.0 g 6.0 14.7 body weighing method 0.0 0 102999 2784
WKY body weight control condition Ohashi H, et al., Jpn Circ J. 1986 Feb;50(2):140-6. body mass male 245 days 7 373.6 g 11.11 29.4 body weighing method 0.0 0 99849 2338
SD body weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 5 302.0 g 6.26 14.0 body weighing method 0.0 unx 13 days 101538 2602
SS-Nppbem2Mcwi-/- body weight vehicle control condition Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. body mass male 252 days 7 452.0 g 21.0 55.56 body weighing method 0.0 0 99760 2319
SD body weight unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 8 300.0 g 10.96 31.0 body weighing method 0.0 unx 28 days 101608 2602
SD body weight streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. body mass male 0 days 8 563.0 g 12.37 35.0 body weighing method 0.0 stz 154 days 99891 2358
SD body weight control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. body mass male 420 days-450 days 9 572.0 g 14.4 43.2 body weighing method 0.0 0 101215 2582
SS-Renem1Mcwi+/+ body weight controlled sodium content diet (0.4 %) (for 49 days) Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. body mass female 70 days 8 204.5 g 3.31 9.36 body weighing method 0.0 0 98292 2038
WKY body weight streptozotocin (60 mg/kg) then gene transfer of the enhanced green fluorescent protein gene using an adenovirus vector (40000000000 null) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 261.43 g 21.34 67.48 body weighing method 0.0 0 99109 2219
WKY body weight streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 287.24 g 20.18 63.81 body weighing method 0.0 0 99111 2219
WKY body weight streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 286.6 g 21.95 69.41 body weighing method 0.0 0 99112 2219
SD body weight left nephrectomy then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 257.0 g 4.0 10.58 body weighing method 0.0 unx 0 98926 2179
SD body weight left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 256.0 g 3.0 7.94 body weighing method 0.0 unx 0 98928 2179
SS/Hsd body weight gain artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. body mass male 52 days-61 days 0 58.0 g 4.0 body weighing method 0.0 0 change from surgery weight (2wks) 103216 2801
SS/Hsd body weight gain aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. body mass male 52 days-61 days 0 61.0 g 6.0 body weighing method 0.0 0 change from surgery weight (2wks) 103217 2801
WKY body weight 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 9 244.0 g 8.0 24.0 body weighing method 0.0 0 100427 2479
WKY body weight controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 5 245.0 g 12.0 26.83 body weighing method 0.0 PA IV 50mg/kg 15 days 100429 2479
WF/Mol body weight gain vehicle control condition then artificial aortocaval fistula (for 2 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 7 -14.0 g 2.0 5.29 body weighing method 0.0 acf 2 days change from surgery weight 101334 2585
WF/Mol body weight gain controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 8 -5.0 g 2.0 5.66 body weighing method 0.0 acf 4 days change from surgery weight 101336 2585
SS.ZUC-Leprfa+/+/Slc body weight bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. body mass female 91 days 9 294.0 g 6.0 18.0 body weighing method 0.0 ovariectomy 42 days 101661 2622
SS.ZUC-Leprfa-/-/Slc body weight bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. body mass female 91 days 8 393.0 g 6.0 16.97 body weighing method 0.0 ovariectomy 42 days 101663 2622
SR/NEisSlc body weight controlled sodium chloride content diet (8 %) (for 21 days) Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13. body mass male 77 days 7 371.0 g 4.54 12.0 body weighing method 0.0 0 102409 2689
MWF/ZtmRrrc body weight enalapril (50 mg/l) (for 182 days) Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. body mass male 246 days 6 442.0 g 7.35 18.0 body weighing method 0.0 0 100906 2541
WKY body weight puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 9 297.0 g 4.0 12.0 body weighing method 0.0 PA IV 50mg/kg 0 100431 2479
WKY body weight puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 8 418.0 g 15.0 42.43 body weighing method 0.0 PA IV 50mg/kg 490 days 100434 2479
WF/Mol body weight controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 7 181.0 g 3.0 7.94 body weighing method 0.0 acf 7 days 101304 2585
WF/Mol body weight vehicle control condition then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 7 184.0 g 3.0 7.94 body weighing method 0.0 acf 7 days 101306 2585
WF/Mol body weight controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 8 189.0 g 2.0 5.66 body weighing method 0.0 acf 2 days 101310 2585
WF/Mol body weight vehicle control condition then sham surgical control condition (for 2 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 6 200.0 g 2.0 4.9 body weighing method 0.0 2 days 101313 2585
WF/Mol body weight controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 8 187.0 g 1.0 2.83 body weighing method 0.0 acf 4 days 101314 2585
WF/Mol body weight controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 7 203.0 g 3.0 7.94 body weighing method 0.0 acf 7 days